TeleMed2U Review
TeleMed2U is a general telehealth platform founded in approximately 2013 in Sacramento, California — making it one of the longer-operating telemedicine companies in the US market. Unlike the wave of GLP-1-specific platforms that emerged during the semaglutide shortage period, TeleMed2U is a primary care and specialty telehealth service that offers GLP-1 prescriptions as part of broader weight management care, not as a standalone product.
Quick Facts
| Starting Price | Contact provider |
| Medications | 2 peptides |
| Consultation | Hybrid |
| Shipping | 3-5 business days |
| Lab Testing | Not included |
| Prescriber | Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility. |
TeleMed2U offers 2 peptides for GLP-1 therapy. TeleMed2U is a general telehealth platform founded in approximately 2013 in Sacramento, California — making it one of the longer-operating telemedicine companies in the US market. Unlike the wave of GLP-1-specific platforms that emerged during the semaglutide shortage period, TeleMed2U is a primary care and specialty telehealth service that offers GLP-1 prescriptions as part of broader weight management care, not as a standalone product.
Pros & Cons
What We Like
- Insurance accepted for consultations
- Established since 2013
- Primary care breadth means GLP-1 treatment is embedded in comprehensive care, not isolated from the rest of your health
- Video consultations with physicians
- Branded GLP-1 prescriptions through primary care are a more straightforward regulatory pathway than compounding
- California regulation and longer track record provide some additional baseline accountability
Watch Out For
- Not a GLP-1-specialist platform
- Branded GLP-1 medications can be expensive without strong insurance coverage; patients without obesity coverage may face high out-of-pocket medication costs
- Requires scheduled video appointments
- Insurance acceptance means billing complexity; not all plans cover telehealth visits or GLP-1 medications equally
- Less marketing visibility than dedicated GLP-1 platforms, which can make it harder to find patient reviews and comparative information
Pricing Breakdown
Pricing not yet verified for TeleMed2U. Visit their site for current pricing →
Medications Offered
2 peptides available through TeleMed2U.
Semaglutide
weight-loss · Subcutaneous injection (weekly)
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
weight-loss · Subcutaneous injection (weekly)
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Considering TeleMed2U?
Request a free, no-obligation consultation. We'll share your details with TeleMed2Uand they'll reach out within 1–2 business days.
TeleMed2U — Full Profile
TeleMed2U — Provider Profile
Overview
TeleMed2U is a general telehealth platform founded in approximately 2013 in Sacramento, California — making it one of the longer-operating telemedicine companies in the US market. Unlike the wave of GLP-1-specific platforms that emerged during the semaglutide shortage period, TeleMed2U is a primary care and specialty telehealth service that offers GLP-1 prescriptions as part of broader weight management care, not as a standalone product.
April 2026 context: TeleMed2U's model is meaningfully different from dedicated GLP-1 platforms. GLP-1 access here comes through a primary care physician relationship — the patient presents for a telehealth visit, the doctor evaluates their overall health picture, and weight management including GLP-1 prescriptions is addressed as part of that conversation. This is closer to how GLP-1 medications are prescribed in traditional medicine than the direct-to-consumer intake-and-prescribe model used by most GLP-1-focused platforms.
That distinction matters in the April 2026 regulatory environment. TeleMed2U's reliance on branded GLP-1 prescriptions through primary care physicians, rather than compounded alternatives through a separate pharmacy pipeline, means it is less exposed to the compounding enforcement pressures affecting smaller direct-access platforms.
The insurance acceptance is TeleMed2U's most significant differentiator in this category. For patients whose health plans cover telehealth primary care visits, consultation costs may be partially or fully covered. GLP-1 medication costs depend on individual insurance plans and formularies — verify at telemed2u.com.
Medications Offered
- Branded GLP-1 medications — Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) available through primary care physician prescriptions; verify current availability at telemed2u.com
- Primary care medications — Full range of medications appropriate to primary care scope
- Compounded GLP-1 medications — Not confirmed; TeleMed2U's model is oriented toward branded prescriptions through primary care; verify at telemed2u.com
Note: Orforglipron (Eli Lilly's oral GLP-1) is not yet FDA-approved as of April 2026 — PDUFA date is April 10, 2026. It is not available through any telehealth platform at this time.
Pricing
| Item | Cost | Notes |
|---|---|---|
| Telehealth consultation | Insurance or cash-pay; verify at telemed2u.com | Insurance accepted |
| GLP-1 medication | Depends on insurance plan; verify at telemed2u.com | Branded medications; copay/coverage varies |
| Follow-up visits | Verify at telemed2u.com | — |
TeleMed2U accepts insurance for consultations, which is a meaningful difference from cash-pay-only GLP-1 platforms. However, medication costs for branded GLP-1s depend heavily on individual insurance plans — patients without GLP-1 obesity coverage may face retail costs of $900–$1,400+/month for Wegovy or Zepbound without manufacturer coupons or savings programs. Confirm your specific coverage situation before enrolling. Verify all costs at telemed2u.com.
States Served
TeleMed2U is California-founded and regulated, and serves patients in multiple states. The specific states covered should be verified at telemed2u.com, as telehealth licensure requirements vary and coverage may change. As a more established platform operating since 2013, state coverage is likely broader than many newer GLP-1-specific providers.
Insurance
- Insurance accepted for telehealth consultations — a notable differentiator in this market
- GLP-1 medication coverage depends on individual insurance plan; obesity coverage varies widely by plan and employer
- Medicare GLP-1 bridge coverage for obesity is pending as of April 2026; verify current status
- HSA/FSA likely accepted for out-of-pocket costs; confirm at telemed2u.com
- Patients with commercial insurance covering telehealth primary care should verify coverage details before scheduling
Consultation Process
TeleMed2U uses video consultations with primary care physicians — a model closer to traditional telemedicine than the async intake processes used by GLP-1-specific platforms.
- Create an account and complete an intake form covering your medical history, current medications, and reason for visit
- Select a telehealth visit type (primary care, weight management, or relevant specialty)
- Schedule a video appointment with a licensed primary care physician
- Attend the video consultation — physician evaluates your overall health and discusses weight management options including GLP-1 medications if appropriate
- If GLP-1 treatment is appropriate, physician prescribes branded medication to your preferred pharmacy
- Manage insurance and pharmacy logistics directly; TeleMed2U provides the clinical visit and prescription
- Schedule follow-up visits through the platform as needed
This model requires more patient engagement than a simple async intake, but provides a real-time clinical conversation and a prescription from a physician who has reviewed your full health picture.
Pros
- Insurance accepted for consultations — reduces out-of-pocket costs for patients with telehealth coverage
- Established since 2013 — substantially longer operating history than most GLP-1-specific platforms
- Primary care breadth means GLP-1 treatment is embedded in comprehensive care, not isolated from the rest of your health
- Video consultations with physicians — more interaction than async-only platforms
- Branded GLP-1 prescriptions through primary care are a more straightforward regulatory pathway than compounding
- California regulation and longer track record provide some additional baseline accountability
Cons
- Not a GLP-1-specialist platform — less streamlined for patients specifically seeking weight management versus general primary care
- Branded GLP-1 medications can be expensive without strong insurance coverage; patients without obesity coverage may face high out-of-pocket medication costs
- Requires scheduled video appointments — less convenient than async platforms for patients who prefer low-friction access
- Insurance acceptance means billing complexity; not all plans cover telehealth visits or GLP-1 medications equally
- Less marketing visibility than dedicated GLP-1 platforms, which can make it harder to find patient reviews and comparative information
Best For
Patients who want GLP-1 prescriptions embedded in genuine primary care, accept insurance (including Medicaid or employer plans with telehealth benefits), and prefer video consultations over async intake questionnaires. TeleMed2U is also a reasonable option for patients in California or nearby states who want a longer-established platform rather than one of the newer direct-to-consumer GLP-1 startups. The insurance angle is the clearest reason to choose TeleMed2U over a cash-pay dedicated GLP-1 platform — if your plan covers it, the consultation cost may be substantially lower.
Editorial Verdict
TeleMed2U occupies a different part of the telehealth market than most providers in this category. It is not a GLP-1-first platform — it is a primary care telehealth service that prescribes GLP-1 medications as part of comprehensive care. That distinction has real implications.
The advantages: longer operating history, insurance acceptance, branded prescriptions through primary care physicians, video-based clinical visits. Patients whose insurance covers telehealth primary care and whose plans have GLP-1 coverage (or who can access manufacturer savings programs) may find TeleMed2U a cost-effective and clinically appropriate route to these medications.
The limitations: it is not optimized for patients who want the fastest, cheapest path to a GLP-1 prescription with minimal friction. The scheduling requirement, the insurance navigation, and the primary care framing all add steps compared to async platforms. And for patients without strong GLP-1 insurance coverage, branded medications through TeleMed2U may ultimately cost more than compounded alternatives through a cash-pay platform — though the regulatory risk of compounded GLP-1s must factor into that calculation.
Verify all costs, coverage, and current state availability at telemed2u.com. TeleMed2U is best approached as a primary care provider that happens to prescribe GLP-1s, not as a GLP-1 platform that happens to accept insurance.
Related Content
- Best GLP-1 Weight Loss Programs 2026 — All providers ranked
- Who Qualifies for GLP-1 Medications? — Eligibility overview
- GLP-1 Cost & Insurance FAQ — What you'll actually pay
- How Much Does Semaglutide Cost? — Full cost breakdown
Patient Reviews
No patient reviews on Telehealth Ally yet. Be the first to review TeleMed2U
Used TeleMed2U? Help others decide.
Leave your email and we'll send you a short, 3-minute review form. Your honest experience helps the next patient make a better choice.
We'll only email you once about this review. No spam. Write a review now
How TeleMed2U Compares
See how TeleMed2U stacks up against other GLP-1 providers.
Provider Comparisons
Medication Comparisons
Ready to explore TeleMed2U?
Based on our independent review, TeleMed2U offers 2 peptides for GLP-1 therapy. Request a free consultation or visit their site to get started.
Telehealth Ally may receive compensation when you request a consultation. This does not affect our rankings or reviews.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
How We Review Providers
Our editorial team independently evaluates every telehealth provider based on pricing transparency, medication availability, clinical protocols, and patient experience. We verify pricing data weekly and update reviews when providers change their offerings. Revenue never influences our rankings or recommendations.
Read our editorial standards →